1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Current Studies at Motherisk: Alcohol Use during Pregnancy
The Motherisk drug testing lab is developing a new screening test to determine prenatal alcohol exposure in newborns. The procedure involves lab analysis of meconium (the newborn's first stool after birth), that is collected from diapers.
This test is entirely non-invasive. The goal is to help physicians in the early identification and treatment of children who may be affected by heavy prenatal alcohol exposure. Health care and social service providers are strongly encouraged to refer pregnant women with a history of drinking to our lab. Women who abstained from alcohol during pregnancy can enroll as controls.
Participants will be asked to consent to the release of medical records pertaining to the pregnancy and the newborn, as well as the collection of a meconium sample directly from the infant's diaper. All data collected will be treated anonymously and with highest confidentiality for research purposes only.
For more information please contact J. Gareri, Study Coordinator, at (416) 813-7709 or by e-mail